Skip to main content

Cost and benefit of beta-lactam resistance in Streptococcus pneumoniae: interplay between the resistance determinants and the cell elongation/division components

Project description

Understanding if the winner pays a price in antimicrobial resistance

Streptococcus pneumoniae (S. pneumoniae) causes a number of infections including pneumonia and meningitis. Several multidrug-resistant strains have emerged whose resistance appears to be tied to mutations in an enzyme domain in three of its six penicillin-binding proteins. Interestingly, while these mutations impart antibacterial resistance, they do not appear to affect enzyme function. The enzyme is important in cell growth and division mediated by peptidoglycan biosynthesis. StreptoMANIAC plans to figure out if antimicrobial resistance in S. pneumoniae affects peptidoglycan biosynthesis and the cell cycle. Ultimately, scientists hope to determine the potential costs to S. pneumoniae of resisting antibiotic-induced death, or if it is a win-win situation.

Call for proposal

H2020-MSCA-IF-2018
See other projects for this call

Funding Scheme

MSCA-IF-EF-CAR - CAR – Career Restart panel

Coordinator

UNIVERSITA DEGLI STUDI DI TRENTO
Address
Via Calepina 14
38122 Trento
Italy
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 183 473,28